T

    TherapeuticsMD Inc (TXMD)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $2.18
    -0.04 (-1.80%)

    Market Cap: $25.23M

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    41%(14/34)
    Avg Surprise
    -32.41%
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    Reported Aug 11
    		$0.01N/AN/ABeat-80.0%
    Mar 26
    Reported May 12
    		$0.00$0.00N/ABeat-100.0%
    Dec 25
    Reported Mar 30
    		$0.00$0.00N/ABeat-100.0%
    Sep 25
    Reported Nov 12
    		$0.00$0.00N/ABeat+100.0%
    Jun 25
    Reported Aug 12
    		$0.05$0.00N/ABeat+152.9%
    Mar 25
    Reported May 13
    		$0.02N/AN/ABeat+128.6%
    Dec 24
    Reported Mar 27
    		$0.02$0.04-45.25%Miss+127.4%
    Sep 24
    Reported Nov 12
    		$-0.05$0.04-232.00%Miss+83.5%
    Jun 24
    Reported Aug 12
    		$-0.09$0.03-415.00%Miss+60.6%
    Mar 24
    Reported May 10
    		$-0.08$0.03-355.33%Miss+68.1%
    Dec 23
    Reported Mar 29
    		$-0.08$-0.13+38.46%Beat-101.0%
    Sep 23
    Reported Nov 14
    		$-0.32$-0.05-540.00%Miss+89.8%
    Jun 23
    Reported Aug 14
    		$-0.24$-0.07-242.86%Miss-101.9%
    Mar 23
    Reported May 15
    		$-0.24$0.06-500.00%Miss+95.8%
    Dec 22
    Reported Mar 27
    		$8.23$-1.11+841.44%Beat+264.6%
    Sep 22
    Reported Nov 14
    		$-3.13$-2.04-53.43%Miss+43.1%
    Jun 22
    Reported Aug 15
    		$12.39$-3.04+507.57%Beat+325.3%
    Mar 22
    Reported May 16
    		$-5.69$-4.00-42.25%Miss-3.5%
    Dec 21
    Reported Mar 10
    		$-5.00$-3.83-30.55%Miss+33.3%
    Sep 21
    Reported Nov 11
    		$-5.50$-5.00-10.00%Miss+8.3%
    Jun 21
    Reported Aug 4
    		$-5.50$-5.50+0.00%Beat+42.1%
    Mar 21
    Reported May 6
    		$-5.50$-5.80+5.17%Beat+47.6%
    Dec 20
    Reported Mar 2
    		$-7.50$-5.25-42.86%Miss+21.1%
    Sep 20
    Reported Nov 9
    		$-6.00$-6.70+10.45%Beat+7.7%
    Jun 20
    Reported Aug 6
    		$-9.50$-8.17-16.28%Miss+0.0%
    Mar 20
    Reported May 6
    		$-10.50$-9.30-12.90%Miss-31.3%
    Dec 19
    Reported Feb 20
    		$-9.50$-9.36-1.50%Miss-11.8%
    Sep 19
    Reported Nov 6
    		$-6.50$-9.50+31.58%Beat+18.8%
    Jun 19
    Reported Aug 6
    		$-9.50$-8.81-7.83%Miss-26.7%
    Mar 19
    Reported May 6
    		$-8.00$-8.49+5.77%Beat-45.5%
    Dec 18
    Reported Feb 21
    		$-8.50$-8.50+0.00%Beat-70.0%
    Sep 18
    Reported Nov 7
    		$-8.00$-9.58+16.49%Beat-128.6%
    Jun 18
    Reported Jul 30
    		$-7.50$-6.17-21.56%Miss-50.0%
    Mar 18
    Reported May 3
    		$-5.50$-4.95-11.11%Miss+0.0%
    Dec 17
    Reported Feb 20
    		$-5.00$-4.25-17.65%Miss+16.7%
    Sep 17
    Reported Nov 6
    		$-3.50$-5.39+35.06%Beat+46.2%
    Jun 17
    Reported Aug 3
    		$-5.00$-5.43+7.92%Beat-
    Mar 17
    Reported May 2
    		$-5.50$-5.58+1.43%Beat-
    Dec 16
    Reported Feb 23
    		$-6.00$-6.21+3.38%Beat-
    Sep 16
    Reported Nov 3
    		$-6.50$-6.00-8.33%Miss-

    Key Metrics

    Valuation
    P/E Ratio21.00EV/EBITDA14.81x
    Price/FCF8.15xFCF Yield12.27%
    Profitability
    Profit Margin-6.64%Operating Margin-32.20%
    ROE-1.08%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio3.22xQuick Ratio3.22x
    Trading Statistics
    Beta0.64Avg Volume32.36K
    52-Week High$2.9552-Week Low$0.99

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.14
    SMA 20$2.10
    SMA 50$2.07
    SMA 200$2.06
    EMA 10$2.16
    EMA 20$2.12
    EMA 50$2.09
    EMA 200$1.95

    MACD

    Line: 0.04Signal: 0.03Hist: 0.02

    ADX

    ADX: 31.9+DI: 32.5-DI: 12.0

    Aroon & PSAR

    Aroon Up88.0
    Aroon Down64.0
    PSAR$2.04

    Bollinger Bands

    Upper Band$2.27
    Lower Band$1.94
    %B Position1597%(Upper)
    Band Width0.73

    RSI (14-Day)

    Neutral
    58.8

    Momentum Oscillators

    Stoch %K64.6
    Stoch %D74.3
    Williams %R-43.8
    ROC (10d)8.5%
    Momentum0.17
    CCI (20d)101.7
    MFI (14d)64.1

    Volatility Measures

    ATR (14d)$0.08(3.5%)
    StdDev (20d)0.08
    Hist Vol41.0%(High)

    Volume Flow

    VWAP$2.21
    OBV11.0M
    AD Line-3.3M
    CMF (20d)-0.004

    Volume Metrics

    Avg Vol (20d)33.2K
    Vol Ratio1.4x
    VWMA (20d)$2.17

    Pivot Points

    R3$2.35
    R2$2.33
    R1$2.27
    Pivot Point$2.25
    S1$2.19
    S2$2.17
    S3$2.11

    Advanced Oscillators

    TSI21.14
    Ultimate Osc48.4
    KST39.53

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$869,000$724,000$893,000$784,000$952,000$393,000$667,000$547,000$234,000$313,000$502,000$-53,000
    Cost of Revenue$0$0$906,000$0$0$0N/A$0$0$0$637,000$0
    Gross Profit$869,000$724,000$893,000$784,000$952,000$393,000$667,000$547,000$234,000$313,000$502,000$-53,000
    Operating Expenses$1.69M$1.45M$2.85M$1.65M$1.65M$1.67M$1.71M$1.68M$3.02M$1.46M$2.11M$1.72M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$1.58M$1.35M$2.70M$1.52M$1.55M$1.49M$1.61M$1.58M$1.58M$1.32M$1.48M$1.59M
    Operating Income$-816,000$-723,000$-1,962,000$-862,000$-695,000$-1,281,000$-1,047,000$-1,134,000$-2,789,000$-1,142,000$-1,611,000$-1,773,000
    Interest Income$69,000$41,000$0$534,000$29,000$29,000$0$275,000$349,000$0$0$0
    Interest Expense$0$0$0$3,000$0$0$0$3,000$5,000$0$0$20,000
    Income Before Tax$164,000$103,000$-580,000$50,000$545,000$-668,000$83,000$-567,000$-1,050,000$-809,000$-1,584,000$-1,434,000
    Income Tax Expense$0$0$32,000$0$0$-32,000$-31,000$0$0$0$-43,000$0
    Net Income$155,000$95,000$-619,000$152,000$551,000$-653,000$252,000$-609,000$-1,090,000$-734,000$-883,000$-3,378,000
    EBITDA$424,000$387,000$278,000$-385,000$828,000$-448,000$664,000$-743,000$-1,214,000$-676,000$-1,062,000$-1,285,000
    EBIT$95,000$62,000$181,000$-481,000$516,000$-697,000$564,000$-839,000$-1,394,000$-809,000$-1,699,000$-1,414,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about TXMD

    News

    TherapeuticsMD Inc. stock outperforms competitors on strong trading day

    Shares of TherapeuticsMD Inc. (TXMD) rose 10.14% to $2.28 on Tuesday, marking its second consecutive day of gains. This performance occurred during a favorable trading session where the NASDAQ Composite Index and the Dow Jones Industrial Average also saw increases. The article highlights TXMD's outperformance compared to its competitors and the broader market indices.

    MarketWatch•8/25/26•
    Bullish

    TherapeuticsMD Q2 Operating Expenses USD 1.68

    This article reports that TherapeuticsMD's operating expenses for the second quarter were 1.68 USD. The document provides this key financial figure.

    Moomoo•8/23/26•
    Neutral

    TherapeuticsMD Inc. stock outperforms competitors on strong trading day

    TherapeuticsMD Inc. (TXMD) stock increased by 1.48% to $2.06 on a day when the broader market indices, including the NASDAQ Composite and Dow Jones Industrial Average, experienced declines. This marks the second consecutive day of gains for TherapeuticsMD Inc., demonstrating its outperformance relative to competitors during a poor trading session.

    MarketWatch•8/20/26•
    Somewhat-Bullish

    TherapeuticsMD, Inc. Revenue Breakdown – NASDAQ:TXMD

    This article provides a revenue breakdown for TherapeuticsMD, Inc. (NASDAQ: TXMD), highlighting that the greatest contribution to its revenue came from the United States, accounting for $1.79 million USD last year and $1.12 million USD the year prior. The data is presented through TradingView, detailing financial information for the health technology and pharmaceutical company.

    TradingView•8/20/26•
    Neutral

    TherapeuticsMD(TXMD) Stock Options Chain | Quotes & News

    This document is an options chain for TherapeuticsMD (TXMD) stock, providing quotes and news related to the company. It serves as a financial data resource for investors interested in TXMD.

    Moomoo•8/19/26•
    Neutral

    Frequently Asked Questions About TXMD

    Does TXMD pay dividends?
    TherapeuticsMD Inc (TXMD) does not currently pay a regular dividend.
    What is TXMD's P/E ratio?
    TherapeuticsMD Inc has a price-to-earnings (P/E) ratio of 21.00.
    What is TXMD's market cap?
    TherapeuticsMD Inc (TXMD) has a market capitalization of $25.23M with a current stock price of $2.18.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In